What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
Surgery, Hepatocellular carcinoma, Hepatectomy, Internal medicine and Gastroenterology are his primary areas of study.
His Surgery study deals with Liver function intersecting with Cancer staging.
He has researched Hepatocellular carcinoma in several fields, including Chemotherapy, Mortality rate, Carcinoma, Stage and Resection.
His work deals with themes such as Preoperative care, Survival rate, Cirrhosis, Perioperative and Blood transfusion, which intersect with Hepatectomy.
His Internal medicine research incorporates themes from Immunology and Oncology.
The concepts of his Gastroenterology study are interwoven with issues in Tumor size, Hepatitis B, Viral disease, Hepatitis and Hepatitis B virus.
His most cited work include:
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. (1982 citations)
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer (689 citations)
- Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function : implications for a strategy of salvage transplantation (661 citations)
What are the main themes of his work throughout his whole career to date?
Chung Mau Lo mainly investigates Surgery, Liver transplantation, Internal medicine, Hepatocellular carcinoma and Gastroenterology.
His Surgery study is mostly concerned with Hepatectomy, Living donor liver transplantation, Retrospective cohort study, Complication and Vein.
He combines subjects such as Perioperative and Survival analysis with his study of Hepatectomy.
Liver transplantation is a primary field of his research addressed under Transplantation.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Oncology and Hepatitis B virus.
His Hepatocellular carcinoma study combines topics in areas such as Cirrhosis, Carcinoma and Radiology.
He most often published in these fields:
- Surgery (44.64%)
- Liver transplantation (42.05%)
- Internal medicine (34.90%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (34.90%)
- Hepatocellular carcinoma (30.33%)
- Liver transplantation (42.05%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Hepatocellular carcinoma, Liver transplantation, Surgery and Gastroenterology.
As part of his studies on Internal medicine, Chung Mau Lo frequently links adjacent subjects like Oncology.
His Hepatocellular carcinoma research includes themes of Cirrhosis, Hepatectomy and Carcinoma, Pathology.
His Hepatectomy study integrates concerns from other disciplines, such as Survival analysis and Single Center.
His Liver transplantation study necessitates a more in-depth grasp of Transplantation.
His Gastroenterology study incorporates themes from Entecavir and Perioperative.
Between 2015 and 2021, his most popular works were:
- Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. (95 citations)
- Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant. (68 citations)
- Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years (54 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
